Literature DB >> 26337992

Pediatric Appropriate Use Criteria Implementation Project: A Multicenter Outpatient Echocardiography Quality Initiative.

Ritu Sachdeva1, Joseph Allen2, Oscar J Benavidez3, Robert M Campbell4, Pamela S Douglas5, Benjamin W Eidem6, Lara Gold2, Michael S Kelleman4, Leo Lopez7, Courtney E McCracken4, Kenan W D Stern8, Rory B Weiner3, Elizabeth Welch7, Wyman W Lai9.   

Abstract

BACKGROUND: Recently published appropriate use criteria (AUC) for initial pediatric outpatient transthoracic echocardiography (TTE) have not yet been evaluated for clinical applicability.
OBJECTIVES: This study sought to determine the appropriateness of TTE as currently performed in pediatric cardiology clinics, diagnostic yield of TTE for various AUC indications, and any gaps in the AUC document.
METHODS: Data were prospectively collected from patients undergoing initial outpatient TTE in 6 centers. TTE indications (appropriate [A], may be appropriate [M], or rarely appropriate [R]) and findings (normal, incidental, or abnormal) were recorded.
RESULTS: Of the 2,655 studies ordered by 102 physicians, indications rated A, M, and R were found in 1,876 (71%), 316 (12%), and 319 studies (12%), respectively, and 144 studies (5%) were unclassifiable. Twenty-four of 113 indications (21%) were not used. Innocent murmur and syncope or palpitations with no other indications of cardiovascular disease, a benign family history, and normal electrocardiogram accounted for 75% of indications rated R. Pathologic murmur had the highest yield of abnormal findings (40%). Odds of an abnormal finding in an A or M TTE were 6 times that of R (95% confidence interval [CI]: [2.8 to 12.8]). Abnormal findings were more common in patients <1 year of age than in those >10 years of age (odds ratio: 6.4; 95% CI: 4.7 to 8.7). Age was a significant predictor of an abnormal finding after adjusting for indication and site (p < 0.001).
CONCLUSIONS: Most TTEs ordered in pediatric cardiology clinics were for indications rated A. AUC ratings successfully stratified indications based on the yield of abnormal findings. This study identified differences in the yield of TTE based on patient age and most common indications rated R. These findings should inform quality improvement efforts and future revisions of the AUC document.
Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  echocardiography; outpatient; pediatric cardiology

Mesh:

Year:  2015        PMID: 26337992     DOI: 10.1016/j.jacc.2015.06.1327

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  5 in total

1.  Impact of Clinician Engagement on Implementation of the Pediatric Echocardiography Appropriate Use Criteria.

Authors:  Markus S Renno; A Nicole Lambert; Prince Kannankeril; David P Johnson; David A Parra
Journal:  Pediatr Cardiol       Date:  2020-01-14       Impact factor: 1.655

2.  Application of Appropriate Use Criteria for Initial Transthoracic Echocardiography in an Academic Outpatient Pediatric Cardiology Program.

Authors:  Raya Safa; Sanjeev Aggarwal; Amrit Misra; Daisuke Kobayashi
Journal:  Pediatr Cardiol       Date:  2017-07-07       Impact factor: 1.655

3.  A Quality Initiative to Improve Appropriate Use of Initial Outpatient Echocardiography Among Pediatric Cardiologists.

Authors:  Erik L Frandsen; Soultana Kourtidou; Joel S Tieder; Erin Alberda; Brian D Soriano
Journal:  Pediatr Qual Saf       Date:  2020-07-23

4.  Application of Appropriate Use Criteria for Echocardiography in Pediatric Patients with Palpitations and Arrhythmias.

Authors:  Soham Dasgupta; Michael Kelleman; Ritu Sachdeva
Journal:  Pediatr Qual Saf       Date:  2020-10-26

5.  Telehealth and Application of Appropriate Use Criteria for Pediatric Transthoracic Echocardiography.

Authors:  Daphney Kernizan; Shubhika Srivastava; Priya Nigam; Elaine M Geary; Carissa Baker-Smith
Journal:  Pediatr Cardiol       Date:  2022-08-12       Impact factor: 1.838

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.